Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Peptron

1997 FOUNDED
PUBLIC STATUS
61-70 EMPLOYEES
087010 STOCK SYMBOL
$17.44 SHARE PRICE (As of Tuesday Closing)
Description

Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
KRX
Primary Office
  • 37-24, Yuseong-daero, 1628 beon-gil
  • Daejeon, Yuseong-gu 305-811
  • South Korea

+82 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Peptron’s full profile, request a free trial.

Peptron Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$17.27 - $29.75 $267M $17.39 -$0.22 187K 15.3M

Peptron Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 328,078 328,078 434,967 164,833
Revenue 3,514 3,514 2,836 2,687
EBITDA (3,098) (3,098) (3,873) (2,427)
Net Income (3,390) (3,390) (3,904) (2,739)
Total Assets 64,168 64,168 49,643 47,914
Total Debt 21,355 21,355 1,872 1,655
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Peptron Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Peptron‘s full profile, request access.

Request full access to PitchBook